Maxim Announces Second Quarter Fiscal 2009 Results




 * Revenue: $410.7 million
 * GAAP Loss per share: $0.12 (including special expense items)
 * Special expense items reduced GAAP EPS by $0.26
 * Special expense items: $125.9 million pre-tax
 * Cash flow from operations: $71.5 million
 * Share repurchase: $235.1 million
 * Dividend per share: $0.20

SUNNYVALE, Calif., Jan. 29, 2009 (GLOBE NEWSWIRE) -- Maxim Integrated Products, Inc. (Nasdaq:MXIM) reported net revenue of $410.7 million for its fiscal 2009 second quarter ending December 27, 2008, an 18% decline from the $501.2 million revenue recorded in the previous quarter.

Based on Generally Accepted Accounting Principles (GAAP), diluted loss per share was $0.12. The results include $125.9 million in special expense items which primarily consist of the following pre-tax expenses:



 * $42.3 million for stock based compensation related to tendered and
   expiring options
 * $43.8 million for the impairment of end of line manufacturing
   assets
 * $13.6 million for severance and restructuring
 * $12.0 million for the accelerated depreciation related to the
   closure of Dallas wafer fabrication facilities

Balance Sheet Items

Cash flow from operations was $71.5 million after $28.1 million in payments for tendered and expiring options. Total cash, cash equivalents, and short-term investments decreased by $331.0 million during the second quarter to $925.5 million due to:



 * $235.1 million to repurchase of 18.1 million shares of Maxim stock
 * $62.3 million for cash dividends
 * $42.6 million for tax payments for restricted stock units that
   vested during the restatement period and the second quarter of 2009.
 * $33.0 million for the acquisition of Mobilygen
 * $28.6 million in payments for property and equipment

Business Outlook

Maxim's fiscal second quarter net realizable bookings decreased by 34% compared to the first quarter of fiscal 2009 and the Company's 90 day backlog declined by 30% to $206 million. Results for the March quarter are projected to be:



 In millions except
  per share amounts                    Included in GAAP estimates:
 ---------------------------------------------------------------------
                          GAAP     Special Expenses  Stock Based Comp.
 ---------------------------------------------------------------------
 Revenue              $290 - $330
 ---------------------------------------------------------------------
 Gross Margin          46% - 49%           4%               3%
 ---------------------------------------------------------------------
 Operating Expenses   $170 - $173       $3 - $4         $26 - $28
 ---------------------------------------------------------------------

Tunc Doluca, President and Chief Executive Officer, commented, "We finished our December quarter with a very cautious view of the global economy. Revenue as well as customer orders were weak across the board. While our recent review of our markets and customers indicates that bookings pace should improve this quarter, we nevertheless continue to manage expenses prudently. We are on schedule to complete our wafer fab consolidation project. This will improve our manufacturing efficiencies next fiscal year. Additionally, we took several measures to reduce our operating expenses."

"We have been investing in new technology, in our core product lines, and in new product lines both internally and through strategic acquisitions. We believe these investments will pay off in the long term. We expect to weather this storm with our cash flow from operations and strong balance sheet. This combination of cost controls and strategic investments will allow us to emerge from this slowdown stronger than we entered it."

Dividend

A cash dividend for the second quarter of fiscal 2009 of $0.20 per share will be paid on March 6, 2009, to stockholders of record on February 20, 2009.

Conference Call

Maxim has scheduled a conference call on January 29, 2009, at 2:00 p.m. Pacific Time to discuss its financial results for the second quarter of fiscal year 2009 and business outlook. To listen via telephone, dial (866) 814-8470 (toll free) or (703) 639-1369. This call will be webcast by Shareholder.com and can be accessed at Maxim's website at www.maxim-ic.com/Investor.



                 CONSOLIDATED STATEMENTS OF OPERATIONS

                                             Three Months Ended
                                       -------------------------------
                                       Dec. 27,    Sept. 27,  Dec. 29,
                                        2008         2008       2007
                                       --------    --------   --------
                                                (in thousands,
                                            except per share data)
 Net revenues                          $410,675    $501,204   $540,025
 Cost of goods sold (1)                 211,590     209,654    204,320
                                       --------    --------   --------
   Gross profit                         199,085     291,550    335,705
 Operating expenses:
   Research and development (1)         144,283     138,915    138,347
   Selling, general and
    administrative (1)                   64,124      40,243     41,636
   In-process research and
    development (4)                       3,900          --         --
   Impairment of long-lived assets (5)   43,769       7,343         --
   Severance and restructuring (6)       13,597       4,106         --
   Other operating expenses, net (7)     10,252       7,358     15,145
                                       --------    --------   --------
     Total operating expenses           279,925     197,965    195,128
                                       --------    --------   --------
       Operating (loss) income         (80,840)      93,585    140,577
 Interest income and other, net           7,385       9,101     21,926
                                       --------    --------   --------
 (Loss) income before (benefit)
  provision for income taxes           (73,455)     102,686    162,503
 (Benefit) provision for income taxes  (34,671)      35,119     55,483
                                       --------    --------   --------
   Net (loss) income                  $(38,784)    $ 67,567   $107,020
                                       ========    ========   ========

 (Loss) earnings per share:
   Basic                               $ (0.12)    $   0.21   $   0.33
                                       ========    ========   ========
   Diluted                             $ (0.12)    $   0.21   $   0.33
                                       ========    ========   ========

 Shares used in the calculation of
  (loss) earnings per share:
   Basic                                312,718     320,553    320,553
                                       ========    ========   ========
   Diluted                              312,718     323,815    326,284
                                       ========    ========   ========

 Dividends declared per share          $  0.200    $  0.200   $  0.188
                                       ========    ========   ========

 (1) Includes stock-based compensation
     charges as follows:
                                               Three Months Ended
                                       -------------------------------
                                         Dec. 27,  Sept. 27,  Dec. 29,
                                          2008       2008       2007
                                       --------    --------   --------
                                                 (in thousands)

  Cost of goods sold                   $ 30,834    $ 11,920   $ 11,668
  Research and development               33,431      19,419     22,799
  Selling, general and administrative    19,672       6,222      7,249
                                       --------    --------   --------
 Total                                 $ 83,937    $ 37,561   $ 41,716
                                       ========    ========   ========

 Total excluding $42,315 for
  settlement of expiring options and
  tender offer (3)                     $ 41,622    $ 37,561   $ 41,716
                                       ========    ========   ========


                   SCHEDULE OF SPECIAL EXPENSE ITEMS

                                               Three Months Ended
                                       -------------------------------
                                         Dec. 27,  Sept. 27,  Dec. 29,
                                          2008       2008       2007
                                       --------    --------   --------
                                                 (in thousands)
 Cost of Goods Sold:
   Accelerated depreciation (2)        $ 12,024    $ 11,329   $     --
   Stock-based compensation (3)          15,433          --         --
                                       --------    --------   --------
  Total                                $ 27,457    $ 11,329   $     --
                                       ========    ========   ========

  Operating Expenses:
   In process research and
    development (4)                    $  3,900    $     --   $     --
   Impairment of long-lived assets (5)   43,769       7,343         --
   Severance and restructuring (6)       13,597       4,106         --
   Other operating expenses, net (7)     10,252       7,358     15,145
   Stock-based compensation (3)          26,882          --         --
                                       --------    --------   --------
  Total                                $ 98,400    $ 18,807   $ 15,145
                                       ========    ========   ========

 (2) Accelerated depreciation primarily related to long-lived assets
     resulting from the anticipated closure of the Dallas fab
     facility.
 (3) Stock-based compensation related to cash settlement of options
     expiring in October 2008 and tender offer.
 (4) In process research and development related to acquisition of
     Mobilygen Corp.
 (5) Impairment of long-lived assets related to end of line test
     equipment recorded in connection with reduced demand.
 (6) Severance and benefit expenses primarily related to the Business
     Unit and Dallas Fab organizations.
 (7) Expenses, net, primarily associated with the restatement of our
     previously filed financial statements, private litigation and
     other associated activities and certain payroll taxes, interest
     and penalties.


                     CONSOLIDATED BALANCE SHEETS

                                          December 27,    June 28,
                                             2008           2008
                                           ----------    ----------
                                                (in thousands)
                ASSETS
 Current assets:
   Cash and cash equivalents               $  718,200    $1,013,119
   Short-term investments                     207,259       205,079
                                           ----------    ----------
       Total cash, cash equivalents and
        short-term investments                925,459     1,218,198
                                           ----------    ----------

   Accounts receivable, net                   213,370       272,029
   Inventories                                251,661       272,421
   Income tax refund receivable                73,096        14,411
   Deferred tax assets                        214,430       253,490
   Other current assets                        17,681        16,012
                                           ----------    ----------
     Total current assets                   1,695,697     2,046,561
 Property, plant and equipment, net         1,404,233     1,485,200
 Other assets                                 110,052       176,629
                                           ----------    ----------
     TOTAL ASSETS                          $3,209,982    $3,708,390
                                           ==========    ==========


                 LIABILITIES AND STOCKHOLDERS' EQUITY

 Current liabilities:
   Accounts payable                        $   81,657    $   79,673
   Income taxes payable                           832           825
   Accrued salary and related expenses        146,584       249,079
   Accrued expenses                            43,697        68,131
   Deferred income on shipments
    to distributors                            20,597        21,447
                                           ----------    ----------
     Total current liabilities                293,367       419,155
 Other liabilities                             27,625        30,791
 Income taxes payable                         113,107       110,633
 Deferred tax liabilities                      34,793            --
                                           ----------    ----------
     Total liabilities                        468,892       560,579
                                           ----------    ----------

 Stockholders' equity:
   Common stock                                   304       251,799
   Retained earnings                        2,742,567     2,901,139
   Accumulated other comprehensive loss       (1,781)       (5,127)
                                           ----------    ----------
     Total stockholders' equity             2,741,090     3,147,811
                                           ----------    ----------
       TOTAL LIABILITIES &
        STOCKHOLDERS' EQUITY               $3,209,982    $3,708,390
                                           ==========    ==========
 
 
                CONSOLIDATED STATEMENTS OF CASH FLOWS

                                              Three Months Ended
                                    ----------------------------------
                                       Dec. 27,  Sept. 27,   Dec. 29,
                                        2008       2008        2007
                                    ----------  ----------  ----------
                                              (in thousands)
 Cash flows from operating
  activities:
 Net (loss) income                  $ (38,784)  $   67,567  $  107,020
 Adjustments to reconcile
  net (loss) income to net cash
  provided by operating activities:
   Stock-based compensation             83,937      37,561      41,716
   Depreciation and amortization        49,992      46,781      34,479
   Deferred taxes                      169,498       (924)      26,721
   Tax benefit related to
    stock-based compensation         (150,144)       1,062     (3,621)
   Excess tax benefit related to
    stock-based compensation             (409)        (52)       (464)
   In-process research and
    development                          3,900          --          --
   Impairment of long-lived assets      43,769       7,343          --
   Loss (gain) from sale of property,
    plant and equipment                  1,187         700     (9,558)
   Gain from sale of equity
    investments                          (529)          --          --
   Changes in assets and liabilities:
     Accounts receivable                55,476       3,460    (11,292)
     Inventories                         7,780       6,429       5,811
     Other current assets             (71,872)      11,146    (26,760)
     Accounts payable                 (15,595)      15,471     (6,003)
     Income taxes payable             (19,022)      21,503    (49,457)
     Deferred income on shipments
      to distributors                    (712)       (138)         523
     Accrued liabilities - goodwill
      and tender offer payments
      above fair value                (28,093)     (8,948)    (23,753)
     All other accrued liabilities    (18,865)    (51,897)    (20,045)
                                    ----------  ----------  ----------
 Net cash provided by
  operating activities                  71,514     157,064      65,317
                                    ----------  ----------  ----------

 Cash flows from investing
  activities:
   Payments for property, plant
    and equipment                     (28,639)    (37,995)    (76,730)
   Proceeds from sale of property,
    plant, and equipment                   625         322      14,158
   Restricted cash                          --          --    (14,158)
   Other non-current assets              1,960      (3,206)     17,096
   Acquisition                        (30,310)          --    (63,369)
   Purchases of available-for-sale
    securities                         (1,370)     (1,370)     (3,898)
   Proceeds from sales/maturities
    of available-for-sale securities     2,237       2,438     391,885
                                    ----------  ----------  ----------
 Net cash (used in) provided by
  investing activities                (55,497)    (39,811)     264,984
                                    ----------  ----------  ----------

 Cash flows from financing
  activities:
   Excess tax benefit related to
    stock-based compensation               409          52         464
   Mortgage liability                     (10)        (10)        (10)
   Goodwill payments on expiring
    options and tender offer
    payments                           (6,753)     (4,997)    (70,363)
   Cash settlement of vested
    restricted stock units                  --     (1,910)       (835)
   Payouts under the RSU
    loan program                      (27,376)     (8,202)     (5,701)
   Dividends paid                     (62,303)    (64,111)    (60,103)
   Repayment of notes payable          (2,673)          --          --
   Issuance of common stock           (15,174)          --          --
   Common stock repurchases          (235,131)          --          --
                                    ----------  ----------  ----------
 Net cash used in financing
  activities                         (349,011)    (79,178)   (136,548)
                                    ----------  ----------  ----------

 Net (decrease) increase in cash
  and cash equivalents               (332,994)      38,075     193,753
 Cash and cash equivalents:
   Beginning of period               1,051,194   1,013,119     813,673
                                    ----------  ----------  ----------
   End of period                    $  718,200  $1,051,194  $1,007,426
                                    ==========  ==========  ==========

 Total cash, cash equivalents, and
  short-term investments            $  925,459  $1,218,198  $1,154,801
                                    ==========  ==========  ==========

"Safe Harbor" Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include the Company's financial projections for its third quarter of fiscal 2009 ending in March, which includes revenue, gross margin, and operating expense projections; indications that bookings should improve in the current quarter based on the Company's recent review of its markets and customers; the Company's belief that its manufacturing efficiencies will continue to improve in the next fiscal year based upon the completion of its wafer fab consolidation project; the Company's belief that its investments in new technology, in its core product lines, and in new product lines both internally and through strategic acquisitions will pay off in the long term; the Company's expectation that it will weather the current economic storm with its cash flow from operations and strong balance sheet; and the Company's belief that the combination of cost controls and strategic investments will allow the Company to emerge from the current slowdown stronger than it entered it. These statements involve risk and uncertainty. Actual results could differ materially from those forecasted based upon, among other things, general market and economic conditions and market developments that could adversely affect the growth of the mixed-signal analog market, product mix shifts, customer cancellations and price competition, as well as other risks described in the Company's Annual Report on Form 10-K for the fiscal year ended June 28, 2008.

All forward-looking statements included in this news release are made as of the date hereof, based on the information available to the Company as of the date hereof, and the Company assumes no obligation to update any forward-looking statement.

About Maxim

Maxim Integrated Products is a publicly traded company that designs, manufactures, and sells high-performance semiconductor products. The Company reported revenue in excess of $2 billion for fiscal 2008. Maxim was founded over 25 years ago with the mission to deliver innovative analog and mixed-signal engineering solutions that add value to its customers' products. To date, it has developed over 5900 products serving the industrial, communications, consumer, and computing markets. For more information, go to www.maxim-ic.com.

The Maxim Integrated Products, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5753



            

Contact Data